Philip H. Coelho, Director at CATALYST PHARMACEUTICALS, INC. (CPRX), bought 10,000 shares at $1.06 ($11K) on 2016-03-17, disclosed to the SEC on 2016-03-17.
Open-market purchase of $11k CPRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| CPRX | SELL | 2021-08-26 | $264K | — | Filing → |
| AMPE | SELL | 2021-05-25 | $13K | — | Filing → |
| AMPE | SELL | 2021-04-29 | $7K | — | Filing → |